Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

TSXV/PCRX stock hub

TSXV/PCRX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/PCRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

83.5M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/PCRX

In the news

Latest news · TSXV/PCRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E50

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-3.4

P25 -121.5P50 -40.9P75 0.5

ROIC-4.1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/PCRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

CAD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 62.5M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Last refreshed	2026-05-10
Market cap	CAD 83.5M
Price	CAD 0.5
Price currency	CAD
Sector	Healthcare
Sic	5912
Symbol	tsxv/PCRX
Website	https://www.pharmacorprx.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.77%
EV Earnings	-42.17x
EV/FCF	32.56x
EV/Sales	2.99x
FCF yield	2.3%
Forward P/E	50x
P/B ratio	1.6x
P/S ratio	3.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.92%
EBITDA Margin	-1.42%
FCF margin	9.18%
Gross margin	39.72%
Gross Profit	CAD 8.3M
Gross Profit Growth	279.89%
Gross Profit Growth Q	77.63%
Net Income	CAD -1.5M
Pretax Margin	-4%
Profit Margin	-7.09%
ROA	-1.54
ROCE	-2.07
ROE	-3.43
ROIC	-4.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr3y	33.52%
FCF Growth	1,525%
FCF Growth Q	34.05%
OCF Growth	1,505.51%
OCF Growth Q	35.78%
Revenue Growth	260.57x
Revenue Growth Q	74.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.41
Assets	CAD 65.6M
Cash	CAD 25.9M
Current Assets	CAD 29.9M
Current Liabilities	CAD 5.8M
Debt	CAD 4.5M
Debt Equity	CAD 0.09
Debt FCF	CAD 2.37
Equity	CAD 52.3M
Interest Coverage	-21.77
Liabilities	CAD 13.3M
Long Term Assets	CAD 35.7M
Long Term Liabilities	CAD 7.5M
Net Cash	CAD 21.3M
Net Cash By Market Cap	CAD 25.57
Net Cash Growth	78.82%
Net Debt Equity	CAD -0.41
Net Debt FCF	CAD -11.12
Tangible Book Value	CAD 21.7M
Tangible Book Value Per Share	CAD 0.15
WACC	-18.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.14
Inventory Turnover	6.27
Net Working Capital	CAD -1.3M
Quick ratio	4.67
Working Capital	CAD 24.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-46.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	0.46
3Y total return	138.1%
50-day SMA	0.44
50-day SMA vs 200-day SMA	50under200
All Time High	0.88
All Time High Change	-42.86%
All Time High Date	2024-08-28
All Time Low	0.12
All Time Low Change	316.67%
All Time Low Date	2022-09-29
ATR	0.03
Beta	-4.3
Beta1y	-0.18
Beta2y	0.27
Ch YTD	9.89
High	0.53
High52	0.58
High52 Date	2025-06-13
High52ch	-13.79%
Low	0.5
Low52	0.4
Low52 Date	2025-12-09
Low52ch	25%
Ma50ch	13.43%
Price vs 200-day SMA	9.55%
RSI	61.6
RSI Monthly	58.62
RSI Weekly	57.93
Sharpe ratio	0.26x
Sortino ratio	0.51
Total Return	-46.26%
Tr YTD	9.89
Tr1m	19.05%
Tr1w	2.04%
Tr3m	17.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -1.2M
Operating margin	-5.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	147,473,250%
Net Borrowing	-322,987
Shares Insiders	11.65%
Shares Institutions	6.5%
Shares Out	166,926,659
Shares Qo Q	26.75%
Shares Yo Y	46.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 1.5M
Average Volume	146,450.9x
Bv Per Share	0.35
CAPEX	CAD -87,602
Ch1m	19.05
Ch1w	2.04
Ch3m	17.65
Ch3y	138.1
Change	1.01%
Change From Open	0
Close	0.5
Days Gap	1.01
Depreciation Amortization	940,196
Dollar Volume	243,025
Earnings Date	2026-05-14
EBIT	CAD -1.2M
EBITDA	CAD -297,496
EPS	CAD -0.01
F Score	3
FCF	CAD 1.9M
FCF EV Yield	3.07x
FCF Per Share	CAD 0.01
Financing CF	24,709,857
Fiscal Year End	December
Founded	2,021
Goodwill	18,599,223
Income Tax	CAD 586,257
Investing CF	-13,717,485
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Ma150	0.45
Ma150ch	11.53%
Ma20	0.45
Ma20ch	11.36%
Net CF	12,998,739
Next Earnings Date	2026-05-14
Open	0.5
P FCF Ratio	43.5
P OCF Ratio	41.6
Position In Range	0
Ppne	5,481,056
Price Date	2026-05-08
Ptbv Ratio	3.84
Relative Volume	3.32x
Revenue	20,894,507x
SBC By Revenue	1.94x
Share Based Comp	405,663
Tax By Revenue	2.81x
Volume	486,050

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/PCRX pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/PCRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/PCRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.5%

Share of float held by funds and institutions

Insider ownership

+11.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+46.3%

Negative means the company is buying back shares.

Technical

TSXV/PCRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.6

Neutral momentum band

Price vs 200-day MA

+9.6%

50/200-day relationship not available

Beta (5Y)

-4.30

Less volatile than the market

Sharpe ratio

0.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/PCRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/PCRX stock rating?

tsxv/PCRX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/PCRX analysis?

The full report lives at /stocks/tsxv/PCRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/PCRX?

The latest report frames tsxv/PCRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/PCRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.